期刊文献+

由孕甾-3S,5R,6R,16S,20S-五醇合成黄体酮 被引量:2

Synthesis of Progesterone by First Utilizing Pregnana-3S,5R,6R,16S,20S-pentaol,a Clean Oxidation Product of Diosgenin
原文传递
导出
摘要 首次利用薯蓣皂甙元降解产物,孕甾-3S,5R,6R,16S,20S-五醇(3)完成了黄体酮的合成.孕甾-3S,5R,6R,16S,20S-五醇可方便地通过薯蓣皂甙元经由30%双氧水原地产生的过酸氧化降解得到.它经过缩酮化反应、乙酰化反应和串联的脱缩酮-溴代乙酰化反应被转化成关键合成中间体16R-溴孕甾-3S,5R,6R,20S-四醇-3,6,20-三乙酸酯(6).化合物6经锌粉还原、C-3乙酰氧基选择性水解氧化反应和C-5羟基消除反应生成6R,20S-二乙酰氧基孕甾-4-烯-3-酮(10).化合物10经C-6乙酰氧基还原和C-20乙酰氧基水解-氧化生成目标分子黄体酮.合成经10步反应,反应总收率达45.1%. Progesterone was synthesized by first utilizing pregnane-3S,5R,6R,16S,20S-pentaol(3).Compound 3 can convenient prepared through a clean oxidation degradation reaction of diosgenine with 30% hydrogen perhydoxide in formic acid or acetic acid.It was transformed into a key synthetic intermediate,16R-bromopregnane-3S,5R,6R,20S-tetraol-3,6,20-triacetate(6) through a sequence of reaction involved ketalization,acetylation and tandem deketalization-bromino-acetylation.Compound 6 subjected to zinc reduction at C-Br and regiodeacetylation-oxidation at C-3 acetate to provide 6R,20S-diacetoxyl-pregn-4-en-3-one(10).Compound 10 was further converted progesterone through the reduction of C-6 acetate and the deacetylation-oxidation of C-20 acetate.Progesterone was synthesized starting from 3 in 10 steps in 45.1% overall yield.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2010年第22期2331-2337,共7页 Acta Chimica Sinica
基金 上海市教育委员会科研创新(Nos.09YZ164 08YZ70) 上海师范大学一般科研(No.DYL200903)资助项目
关键词 黄体酮 薯蓣皂甙元 孕甾-3S 5R 6R 16S 20S-五醇 资源化学 progesterone diosgenin pregnane-3S 5R 6R 16S 20S-pentaol resource chemistry
  • 相关文献

参考文献16

  • 1Heyl, F. W.; Herr, M. E. J. Am. Chem. Soc. 1950, 2617.
  • 2Raggio, M. L.; Watt, D. S. J. Org. Chem. 1976, 1873.
  • 3Van Leusen, D.; Van Leusen, A. M. Synthesis 1991, 531.
  • 4Mackie, R. K.; Smith, D. M.; Aitken, R. A. Guidebook to Organic Synthesis, 3rd ed., Person Education Limited, Beijing, 2001, pp. 346-347.
  • 5Marker, R. E.; Krueger, J. J. Am. Chem. Soc. 1940, 62, 3349.
  • 6Maximilian, E. Chem. Rev. 1948, 42, 457.
  • 7Daglish, A. F.; Green, J.; Poole, V. D. J. Chem. Soc. 1954, 2627.
  • 8Shepherd, D. A.; Donia, R. A.; Campbell, J. A.; Johnson, B. A.; Holysz, R. P.; Slomp, G. Jr.; Stafford, J. E.; Pederson,R. L.; Ott, A. C.J. Am. Chem. Soc. 1955, 77, 1212.
  • 9Gibert, S.; John, E. M. J. Am. Chem. Soc. 1967, 5464.
  • 10Johnson, W. S.; Gravestock, M. B.; McCarry, B. E. J. Am. Chem. Soc. 1971, 93, 4332.

二级参考文献27

共引文献77

同被引文献39

  • 1岳瑛.必需微量元素与妊娠的关系[J].实用妇产科杂志,1996,12(5):238-239. 被引量:18
  • 2秦锐,陈荣华,王福德,王立珍,成秀岩.妊娠妇女血浆锌水平检测及补锌效果的观察[J].中华妇产科杂志,1996,31(8):496-497. 被引量:8
  • 3江敏,崔鹏,于涛,杨帆,汤杰.3β-羟基雄甾-4-烯-6,17-二酮的合成[J].应用化学,2006,23(12):1422-1424. 被引量:2
  • 4杨乐天,谷丽萍,张为远,范丽梅.妊娠期高血压疾病与血清微量元素锌 铜 铁 锰的关系[J].中国妇幼保健,2007,22(29):4082-4085. 被引量:10
  • 5Rasmusson G H, Reynolds G F, Steinberg N G, et al. Azasteroids: structure - activity relationship for inhibition of 5 - reductase and of androgen acceptor binding[ J ]. Journal of Medicinal Chemistry, 1986,29 (11 ) : 2298 -2315.
  • 6Andriole G L, Kirby R. Safety and tolerability of the dual 5a - reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia[ J]. European Urology, 2003, 44(1) : 82 - 88.
  • 7Huang L H, Zheng Y F, Lu Y Z, et al. Synthesis and biological evaluation of novel steroidal[ 17,16 - d] [ 1,2,4] triazolo[ 1, 5 - a] pyrimidines[ J]. Steroids, 2012, 77 : 710 - 715.
  • 8Robertson J F, Come S E, Jones S E,et al. Endocrine treatment options for advanced breast cancer: the role of fulvestrant[ J]. European Journal of Cancer, 2005, 41 (3) : 346 -356.
  • 9Miller T A, Bulman A L, Thompson C D, et al. Synthesis and structure - activity profiles of A - homoestranes, the estratropones [ J ]. Journal of Medicinal Chemistry, 1997, 40 (23) : 3836 - 3841.
  • 10Cepa M M, Tavares D, Silva E J, et al. Structure - activity relationships of new A, D - ring modified steroids as aromatase inhibitors : design, synthesis, and biological activity evaluation [ J ]. Journal of Medicinal Chemistry, 2005, 48 (20) : 6379 - 6385.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部